NDC 72485-201
Azacitidine 100 mg injection, powder, lyophilized, for solution
On the label: Armas Pharmaceuticals Inc..
Where it's made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Armas Pharmaceuticals Inc. names for other drugs.
Recalls
- Dec 8, 2020 · Class II · Shilpa Medicare Limited
CGMP Deviations
Lots: Lot #s: 7S10115A, Exp. 07/31/2021; 7S10143A, 7S10182B, Exp. 09/30/2021; 7S10255A, 7S10256A, 7S10263A, Exp. 11/30/2021; 7T10028A, 12/31/2021; 7T10040A, Exp. 01/31/2022.
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Azacitidine: every company that makes it
- Form
- injection, powder, lyophilized, for solution, intravenous; subcutaneous
- Strength
- 100 mg
- Approval
- ANDA ANDA207518
- On the market since
- Sep 10, 2018
- Package NDCs
72485-201-01- Official label
- DailyMed (National Library of Medicine), updated Aug 5, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?